JP2003501488A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501488A5
JP2003501488A5 JP2001502887A JP2001502887A JP2003501488A5 JP 2003501488 A5 JP2003501488 A5 JP 2003501488A5 JP 2001502887 A JP2001502887 A JP 2001502887A JP 2001502887 A JP2001502887 A JP 2001502887A JP 2003501488 A5 JP2003501488 A5 JP 2003501488A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
liquid pharmaceutical
complex
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501488A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/016052 external-priority patent/WO2000076556A2/en
Publication of JP2003501488A publication Critical patent/JP2003501488A/ja
Publication of JP2003501488A5 publication Critical patent/JP2003501488A5/ja
Pending legal-status Critical Current

Links

JP2001502887A 1999-06-11 2000-06-12 骨髄抑制のための高投与量放射性核種錯体 Pending JP2003501488A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60/139,065 1999-06-11
US13906599P 1999-07-11 1999-07-11
US14378099P 1999-07-13 1999-07-13
US60/143,780 1999-07-13
US14982199P 1999-08-19 1999-08-19
US60/149,821 1999-08-19
PCT/US2000/016052 WO2000076556A2 (en) 1999-06-11 2000-06-12 High dose radionuclide complexes for bone marrow suppression

Publications (2)

Publication Number Publication Date
JP2003501488A JP2003501488A (ja) 2003-01-14
JP2003501488A5 true JP2003501488A5 (US07119074-20061010-C00003.png) 2007-08-02

Family

ID=27385279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502887A Pending JP2003501488A (ja) 1999-06-11 2000-06-12 骨髄抑制のための高投与量放射性核種錯体

Country Status (6)

Country Link
US (6) US6767531B2 (US07119074-20061010-C00003.png)
EP (1) EP1191948A2 (US07119074-20061010-C00003.png)
JP (1) JP2003501488A (US07119074-20061010-C00003.png)
AU (1) AU5871000A (US07119074-20061010-C00003.png)
CA (1) CA2371728C (US07119074-20061010-C00003.png)
WO (1) WO2000076556A2 (US07119074-20061010-C00003.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
AU2001265248A1 (en) * 2000-05-31 2001-12-11 Mccullough, Steven Measurement of the therapeutic dose for bone marrow ablation therapy
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
AU2002249935A1 (en) 2001-01-08 2002-08-19 Neorx Corporation Radioactively labelled conjugates of phosphonates
WO2003051403A1 (en) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
WO2004052408A1 (en) * 2002-12-10 2004-06-24 University Of Miami Radioablation of hemolymphopoietic cell populations
EP1475105A1 (en) * 2003-05-09 2004-11-10 Schering AG Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
US20070092440A1 (en) * 2003-05-09 2007-04-26 Edgar Braendle Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
US8709380B1 (en) * 2006-02-07 2014-04-29 Sirius Medicine, Llc Targeting agents for enhancing radiation therapy
WO2007126730A1 (en) * 2006-03-29 2007-11-08 Isotherapeautics Group Llc Radionuclide therapy for urinary bladder cancer
WO2008063693A2 (en) * 2006-04-14 2008-05-29 Thorenco, Llc Compound isotope target assembly for production of medical and commercial isotopes by means of spectrum shaping alloys
US8198264B2 (en) * 2006-04-28 2012-06-12 National Cancer Center Method for treating head and neck cancer
TW200809194A (en) * 2006-05-04 2008-02-16 Wyeth Corp Determination of antibiotic concentration in bone
US20080114063A1 (en) * 2006-08-16 2008-05-15 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases
US9993437B2 (en) 2007-12-06 2018-06-12 The Regents Of The University Of California Mesoporous silica nanoparticles for biomedical applications
US20100310465A1 (en) * 2008-01-23 2010-12-09 The Regents Of The University Of California Nano-devices having releasable seals for controlled release of molecules
WO2010011927A1 (en) 2008-07-25 2010-01-28 Noventis, Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
US8734816B2 (en) * 2009-01-05 2014-05-27 Stc.Unm Porous nanoparticle supported lipid bilayer nanostructures
US8702664B2 (en) * 2009-02-18 2014-04-22 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation
US20120207795A1 (en) * 2010-07-13 2012-08-16 The Regents Of The University Of California Cationic polymer coated mesoporous silica nanoparticles and uses thereof
CA2806208C (en) 2010-07-22 2018-02-13 Zishan Haroon Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution
JP2014512409A (ja) 2011-04-28 2014-05-22 エスティーシー. ユーエヌエム 標的送達用の多孔性ナノ粒子に担持された脂質二重層(プロトセル)及びその使用方法
US10220004B2 (en) 2011-07-14 2019-03-05 The Regents Of The University Of California Method of controlled delivery using sub-micron-scale machines
HUE062439T2 (hu) * 2013-10-07 2023-11-28 Igl Pharma Inc Eljárás nagy tisztaságú terápiás csont szerek elõállítására
RU2599874C2 (ru) * 2014-10-13 2016-10-20 Михаил Сергеевич АНОСОВ Способ лечения хронического одонтогенного остеомиелита у наркозависимых больных
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
EP3302496B1 (en) * 2015-05-25 2021-01-06 IGL Pharma, Inc. Dotmp kit formulations for radioisotopes
EP3386546A1 (en) 2015-12-07 2018-10-17 General Oncology, Inc. Combination for the effective treatment of metastatic cancer in patients
WO2017120504A1 (en) 2016-01-08 2017-07-13 Durfee Paul N Osteotropic nanoparticles for prevention or treatment of bone metastases
US11344629B2 (en) 2017-03-01 2022-05-31 Charles Jeffrey Brinker Active targeting of cells by monosized protocells
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
JP2020518673A (ja) 2017-05-05 2020-06-25 フュージョン・ファーマシューティカルズ・インコーポレイテッド 二官能性キレートの薬物動態増強及びその使用
KR20200004861A (ko) 2017-05-05 2020-01-14 퓨전 파마슈티칼즈 인크. Igf-1r 모노클로날 항체 및 그의 용도
CA3084369A1 (en) 2017-12-07 2019-06-13 Reven, Llc Compositions and methods for the treatment of metabolic conditions
JP2022513399A (ja) * 2018-10-29 2022-02-07 モレキュラー ステソスコープ, インコーポレイテッド 無細胞メッセンジャーrnaを使用した骨髄の特徴付け
TW202112358A (zh) * 2019-06-12 2021-04-01 美商里文Ip控股有限責任公司 用於改善癌症病患之成效的方法及組成物
US11654300B2 (en) 2020-01-28 2023-05-23 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Family Cites Families (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US118508A (en) * 1871-08-29 Improvement in flour-bolts
US96393A (en) * 1869-11-02 Improved furniture-caster
US587451A (en) * 1897-08-03 James douglas o neill
US410436A (en) * 1889-09-03 packham
US158393A (en) * 1875-01-05 Improvement in grates
US470753A (en) * 1892-03-15 William grunow
US589190A (en) * 1897-08-31 Apparatus for compressing air
US716818A (en) * 1901-04-13 1902-12-23 James A Ekin Criswell Machine for making matches.
US937333A (en) * 1909-06-26 1909-10-19 William H Shugart Rail-joint.
GB750155A (en) 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines
US3032585A (en) 1954-12-03 1962-05-01 Nat Res Dev Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine
US3398097A (en) 1965-07-30 1968-08-20 Progressive Products Co Cleaning composition, and method of cleaning and sequestering metal ions
BE744394A (en) * 1970-01-14 1970-07-14 Elphiac Sa Zone refining process
US3726912A (en) 1970-07-02 1973-04-10 Dow Chemical Co Substituted alkanolamine chelating agents
US3989730A (en) 1972-06-15 1976-11-02 Research Corporation Bone-seeking technetium-99m complex
US3852414A (en) 1972-09-13 1974-12-03 New England Nuclear Corp Bone seeking technetium 99m stannous phosphate complex
PH12898A (en) * 1973-05-23 1979-10-04 Procter & Gamble A composition for the treatment of calcific tumors
US3965254A (en) 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US3931396A (en) 1973-05-31 1976-01-06 Commissariat A L'energie Atomique Method of preparation of a composition having a base of 99m technetium for diagnosis by scintigraphy
US4058704A (en) 1974-12-27 1977-11-15 Taeo Kim Coilable and severable heating element
US4017596A (en) 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
US3974268A (en) 1975-05-30 1976-08-10 Research Corporation Bone-seeking technetium-99m imidodiphosphonate complex
DE2543349C2 (de) 1975-09-29 1984-05-10 Henkel KGaA, 4000 Düsseldorf Preaparate zur herstellung von99m technetium-radiagnostica
US4075314A (en) 1976-04-29 1978-02-21 Mallinckrodt, Inc. Stannous pyrophosphate technetium-99m compositions
CA1078731A (en) 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4399817A (en) 1981-06-30 1983-08-23 The Procter & Gamble Company Boron containing polyphosphonates for the treatment of calcific tumors
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4508625A (en) 1982-10-18 1985-04-02 Graham Marshall D Magnetic separation using chelated magnetic ions
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
DE3247054C1 (de) * 1982-12-20 1984-05-10 Goetze Ag, 5093 Burscheid Spritzpulver fuer die Herstellung verschleissfester Beschichtungen
SE8301395L (sv) 1983-03-15 1984-09-16 Wallac Oy Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
US4515767A (en) 1983-06-20 1985-05-07 The Dow Chemical Company Radioactive metals complexed with phosphonate derivatives of dicyclopentadienebis(methylamine)
US4676950A (en) * 1984-02-03 1987-06-30 Foster Research Corporation Indicator and test device for detecting occult blood
US4560548A (en) 1984-04-10 1985-12-24 The Dow Chemical Company Bone seeking Tc-99m complexes of phosphonate derivatives of bis(aminoalkyl)piperazine
US5059412A (en) 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
IL74902A (en) 1984-06-04 1990-12-23 Dow Chemical Co Organic amine phosphonic acid complexes with particle-emitting radionuclides for the treatment of calcific tumors
US5066478A (en) 1984-06-04 1991-11-19 The Dow Chemical Company Radio labeled organic amine phosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US4606907A (en) 1984-07-02 1986-08-19 The Dow Chemical Company Bone seeking Tc-99m complexes of phosphonate derivatives of polyamidoamines
US4897254A (en) 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
US4639365A (en) 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US4678687A (en) * 1984-10-31 1987-07-07 Xerox Corporation Thermal transfer printing sheets containing certain coating compositions thereof
US5556982A (en) 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5393512A (en) 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4752464A (en) 1985-06-07 1988-06-21 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
GB8518300D0 (en) 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
EP0232751B1 (en) 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3625417C2 (de) 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
FR2614020B1 (fr) 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US5202109A (en) 1988-06-10 1993-04-13 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US5089249A (en) 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US4976950A (en) 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4937333A (en) 1989-08-04 1990-06-26 The Dow Chemical Company Method for purifying aminomethylenephosphonic acids for pharmaceutical use
GB8903023D0 (en) 1989-02-10 1989-03-30 Parker David Chemical compounds
US5714467A (en) 1989-04-12 1998-02-03 The Rockefeller University Antibacterial and antimalarial hybrid peptides
GB9002375D0 (en) 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5064433A (en) * 1990-03-05 1991-11-12 Helix Medical, Inc. Voice prosthesis insertion assemblies
DE69124132T2 (de) 1990-04-18 1997-06-05 Celltech Therapeutics Ltd Tetra-aza-makrozyklen, Verfahren zu ihrer Herstellung und ihre Anwendung in NMR-Bildformung
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
ATE118788T1 (de) 1990-06-15 1995-03-15 Hoechst Schering Agrevo Gmbh Antifungisches polypeptid, verfahren zu seiner herstellung.
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
SK280188B6 (sk) 1990-08-20 1999-09-10 Suntory Limited Penem-deriváty a antibiotický prostriedok ktorý ic
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5861430A (en) 1991-12-17 1999-01-19 Jasmine Fockerman Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
US5919925A (en) 1992-01-22 1999-07-06 Pfizer Inc. 2-isocephem and oxacephem derivatives and use as antibacterial agents
ATE210464T1 (de) 1992-06-09 2001-12-15 Neorx Corp BIOTIN-DOTA KONJUGATE UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
BR9307332A (pt) 1992-10-28 1999-06-01 Den Mat Corp Lavagem bucal antibacteriana
US5714604A (en) 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
BR9407567A (pt) 1993-08-24 1996-12-31 Janssen Pharmaceutica Nv Oxatiazinas antibacterianas e antiformadoras de incrustaçoes e seus óxidos
US5587451A (en) 1993-11-26 1996-12-24 The Dow Chemical Company Process for preparing polyazamacrocycles
FR2719481B1 (fr) 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
US5910498A (en) 1994-10-20 1999-06-08 Wakunaga Seiyaku Kabushiki Kaisha Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
JPH09508144A (ja) 1994-11-08 1997-08-19 グラクソ、ウェルカム、ソシエダッド、アノニマ 抗真菌ソルダリン誘導体
AU3696495A (en) 1994-11-17 1996-06-17 F. Hoffmann-La Roche Ag Antibacterial dibenzimidazole derivatives
DE69526958T2 (de) 1994-11-29 2003-01-16 Hisamitsu Pharmaceutical Co Antibakterielle oder bakterizide mittel, die 2-aminothiazolderivate und deren salze enthalten
US5773421A (en) 1995-01-10 1998-06-30 Abbott Laboratories Antifungal fusacandins
ATE206054T1 (de) 1995-01-26 2001-10-15 Merck & Co Inc Neue fungizide cyclohexapeptide
KR19980702014A (ko) 1995-02-08 1998-07-15 모리시타 타다시 항균성 테르펜 화합물 및 그 제조방법
JP3081773B2 (ja) 1995-03-31 2000-08-28 株式会社資生堂 N−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
KR970705560A (ko) 1995-08-02 1997-10-09 호아껭 우리아치 토렐로 항진균 활성을 갖는 신규한 카르복사미드(new carboxamides with antifungal activity)
ATE198593T1 (de) 1995-08-02 2001-01-15 Uriach & Cia Sa J Pyrimidonderivate mit antifungaler wirkung
US5681430A (en) * 1995-08-23 1997-10-28 Thermo Fibertek Inc. Activity induction in papermaking
US5872249A (en) 1995-09-01 1999-02-16 Korea Institute Of Science And Technology 3-ammoniopropenyl cephalosporin compounds as antibacterial agents and process for preparing the same
WO1997010235A1 (en) 1995-09-15 1997-03-20 Pharmacia & Upjohn Company 5-AMIDOMETHYL α, β-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS
EP0881878A4 (en) 1995-09-15 2004-08-04 Anadys Pharmaceuticals Inc ARYLHYDRAZONE DERIVATIVES AS AN ANTIBACTERIAL AGENT
US5837726A (en) 1995-11-01 1998-11-17 Millennium Pharmaceuticals, Inc. Antifungal agents derived from aspergillus fumigatus
EP0781566B1 (en) 1995-12-26 2004-07-28 Toyo Boseki Kabushiki Kaisha Organic solvent-soluble mucopolysaccharide, antibacterial antithrombogenic composition and medical material
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
JP4058129B2 (ja) 1996-03-18 2008-03-05 株式会社資生堂 ピリジン誘導体及び抗潰瘍剤、抗菌剤
US5770617A (en) 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
US5773696A (en) 1996-03-29 1998-06-30 Monsanto Company Antifungal polypeptide and methods for controlling plant pathogenic fungi
JP3693449B2 (ja) 1996-04-05 2005-09-07 三菱製紙株式会社 抗菌防黴剤およびそれを含有する繊維状物質
JP4150435B2 (ja) 1996-04-18 2008-09-17 株式会社資生堂 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
US5756725A (en) 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US5917084A (en) 1996-07-03 1999-06-29 Millennium Pharmaceuticals, Inc. Antifungal agents
GB2315489A (en) 1996-07-17 1998-02-04 Merck & Co Inc Antifungal agent
US5837253A (en) 1996-07-26 1998-11-17 Agrogene Ltd. Preparation and use of Inula extracts as a fungicide for the control of plant diseases
US5908862A (en) 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5830855A (en) 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents
US5876738A (en) 1996-10-29 1999-03-02 Toagosei Co., Ltd. Antifungal phyllosilicate
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
JP4090087B2 (ja) 1997-04-04 2008-05-28 株式会社資生堂 ベンズアミド誘導体及び抗潰瘍剤、抗菌剤
US5863773A (en) 1997-09-30 1999-01-26 Abbott Laboratories Antifungal corynecandin
DE19911329A1 (de) 1998-03-27 2000-09-21 Benes Ivan Friedrich Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
AU2002249935A1 (en) * 2001-01-08 2002-08-19 Neorx Corporation Radioactively labelled conjugates of phosphonates
WO2003051403A1 (en) * 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals

Similar Documents

Publication Publication Date Title
JP2003501488A5 (US07119074-20061010-C00003.png)
JP2001520189A5 (US07119074-20061010-C00003.png)
WO2001039762A3 (en) Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
JP2001525359A5 (US07119074-20061010-C00003.png)
US9012444B2 (en) Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
HUP0300421A2 (hu) Kezelési eljárás ligand-immunogén konjugátumok felhasználásával
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
IL133585A0 (en) Soluble prodrugs of paclitaxel
JP2003501488A (ja) 骨髄抑制のための高投与量放射性核種錯体
AU3331499A (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
CA2596084A1 (en) Treatment of metastasized tumors with quinolinone benzimidazole compounds
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
JP2007511499A (ja) コンビネーション
CA2363973C (en) Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
EP2097085A2 (en) Therapeutic materials and methods
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
TW200517127A (en) Novel composition
RU2005105693A (ru) Применение алкилфосфохолинов и лекарственное средство для лечения опухолевых заболеваний
JP2006523664A5 (US07119074-20061010-C00003.png)
Smith et al. Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck: A phase II Southwest Oncology Group study
US6765104B1 (en) Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use
ES2217265T3 (es) Inhibidor de la metastasis de tumores malignos.
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
DeNardo Editorial Bone Pain Palliation
US20040204435A1 (en) Alternating treatment with topoisomerase I and topoisomerase II inhibitors